⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Investors in MoonLake Immunotherapeutics (MLTX): Protect Your Rights - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
December 15, 2025 Deadline Approaching: Join Class Action Against MoonLake Immunotherapeutics (MLTX) – Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Issues Important Reminder to MoonLake Immunotherapeutics Investors – MLTX
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Moves to SueWallSt For MoonLake Immunotherapeutics Investors That Lost Money
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX